- Active not recruitingPHASE3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine, BLU-5937, for adults in the UK with a long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough over 24 weeks, compared to a dummy pill.
For: Cough · Refractory Chronic CoughUnited States · Australia · Canada - Active not recruitingPHASE3
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine called BLU-5937 for adults with a stubborn, long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough, compared to a dummy pill.
For: Cough · Refractory Chronic CoughUnited States · Argentina · Belgium